This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
GOAT ANTI HUMAN APOLIPOPROTEIN E
catalog :
AHP2177
quantity :
1 ml
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human
product information
Entity Category :
Antibodies
Product Code :
AHP2177
Description :
GOAT ANTI HUMAN APOLIPOPROTEIN E
Specificity :
APOLIPOPROTEIN E
Target Species :
Human
Host :
Goat
Format :
Serum
Isotypes :
Polyclonal IgG
Applications :
E
Application Types :
ELISA
Quantity :
1 ml
Quantity Value :
1 ml
Quantity Type :
ml
GO Accessions :
GO:0000302, GO:0001540, GO:0001937, GO:0007010, GO:0005543, GO:0006641, GO:0006898, GO:0006916, GO:0006917, GO:0007186, GO:0007263, GO:0007271, GO:0008201, GO:0008219, GO:0010544, GO:0010873, GO:0010875, GO:0016209, GO:0019934, GO:0030425, GO:0030516, GO:0030828, GO:0032488, GO:0032805, GO:0033344, GO:0033700, GO:0034361, GO:0034362, GO:0034363, GO:0034364, GO:0034372, GO:0034375, GO:0034380, GO:0034382, GO:0034384, GO:0034447, GO:0046911, GO:0042627, GO:0042632, GO:0042803, GO:0043025, GO:0043407, GO:0043537, GO:0043691, GO:0045541, GO:0046907, GO:0046982, GO:0048156, GO:0048168, GO:0050728, GO:0070326, GO:0050750, GO:0051000, GO:0051044, GO:0060228
GO Terms :
activation of apoptosis, activation of cGMP biosynthetic process, activation of low-density lipoprotein receptor catabolic process, activation of membrane protein ectodomain proteolysis, activation of nitric-oxide synthase activity, anti-inflammatory response, apolipoprotein E receptor binding, apoptosis activator activity, apoptosis inhibitor activity, apoptosis signaling, cGMP-mediated signalling, cholesterol export, commitment to apoptosis, cytoskeletal organization and biogenesis, cytoskeletal regulator activity, cytoskeleton organisation, cytoskeleton organization and biogenesis, dimerization activity, down regulation of blood vessel endothelial cell migration, down regulation of cholesterol biosynthetic process, down regulation of endothelial cell proliferation, down regulation of inflammatory response, down regulation of MAPK activity, downregulation of blood vessel endothelial cell migration, down-regulation of blood vessel endothelial cell migration, downregulation of cholesterol biosynthetic process, down-regulation of cholesterol biosynthetic process, downregulation of endothelial cell proliferation, down-regulation of endothelial cell proliferation, downregulation of inflammatory response, down-regulation of inflammatory response, downregulation of MAPK activity, down-regulation of MAPK activity, G protein coupled receptor protein signaling pathway, G protein coupled receptor protein signalling pathway, GO:0030236, GPCR protein signaling pathway, GPCR protein signalling pathway, G-protein coupled receptor protein signal transduction, G-protein coupled receptor protein signalling pathway, G-protein-coupled receptor protein signaling pathway, G-protein-coupled receptor protein signalling pathway, HDL assembly, HDL clearance, HDL complex, HDL particle, HDL remodeling, HDL2, HDL3, heavy metal chelation, heparan sulfate binding, high-density lipoprotein class complex, IDL complex, IDL formation, IDL particle, induction of apoptosis by p53, inhibition of blood vessel endothelial cell migration, inhibition of cholesterol biosynthetic process, inhibition of endothelial cell proliferation, inhibition of inflammatory response, inhibition of MAPK activity, intermediate-density lipoprotein complex, intermediate-density lipoprotein particle formation, LCAT activator activity, LDL complex, LDL particle, LDL receptor binding, low-density lipoprotein complex, low-density lipoprotein receptor binding, metal chelation, necrosis, negative regulation of cholesterol anabolism, negative regulation of cholesterol biosynthesis, negative regulation of cholesterol formation, negative regulation of cholesterol synthesis, negative regulation of mitogen activated protein kinase activity, negative regulation of mitogen-activated protein kinase activity, neuron cell body, neuronal cell soma, nitric oxide-mediated signal transduction, nitric-oxide synthase activator, NO mediated signal transduction, NO-mediated signal transduction, NOS activator, phospholipid export, positive regulation of cGMP anabolism, positive regulation of cGMP biosynthesis, positive regulation of cGMP formation, positive regulation of cGMP synthesis, positive regulation of low-density lipoprotein particle receptor catabolic process, positive regulation of low-density lipoprotein receptor breakdown, positive regulation of low-density lipoprotein receptor catabolism, positive regulation of low-density lipoprotein receptor degradation, positive regulation of NOS activity, receptor mediated endocytosis, response to active oxygen species, response to AOS, response to reactive oxidative species, response to reactive oxygen intermediate, response to ROI, response to ROS, stimulation of cGMP biosynthetic process, stimulation of low-density lipoprotein receptor catabolic process, stimulation of membrane protein ectodomain proteolysis, stimulation of nitric-oxide synthase activity, triacylglycerol metabolic process, triacylglycerol metabolism, triglyceride metabolism, up regulation of cGMP biosynthetic process, up regulation of low-density lipoprotein receptor catabolic process, up regulation of membrane protein ectodomain proteolysis, up regulation of nitric-oxide synthase activity, upregulation of cGMP biosynthetic process, up-regulation of cGMP biosynthetic process, up-regulation of low-density lipoprotein receptor catabolic process, upregulation of low-density lipoprotein receptor catabolic process, upregulation of membrane protein ectodomain proteolysis, up-regulation of membrane protein ectodomain proteolysis, up-regulation of nitric-oxide synthase activity, upregulation of nitric-oxide synthase activity, very-low-density lipoprotein complex, very-low-density lipoprotein particle receptor binding, VLDL clearance, VLDL complex, VLDL particle, VLDL receptor binding, VLDL remodeling, VLDLR binding
Uniprot Accessions :
P02649
Gene :
APOE
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=348
EntityFormats :
Serum
UNSPSC :
41116161
Product Form :
Serum - liquid
PrimarySecondary :
Primary
NotForSaleInCountries :
Canada
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.